Business
DiaMedica Therapeutics to Report Third Quarter 2019 Financials and Provide a Business Update November 14, 2019
MINNEAPOLIS--(BUSINESS WIRE)-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its third quarter 2019 financial results will be released
About this update from Diamedica Therapeutics Inc.
[{"type":"text","content":" MINNEAPOLIS--(BUSINESS WIRE)--\nDiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its third quarter 2019 financial results will be released after the markets close on Wednesday, November 13th. DiaMedica will host a live conference call on Thursday, November 14th at 7:00 AM Central Time to discuss its business update and financial results.\n\n\nConference Call details:\n\n\n\n\nDate:\n\n\n \n\nThursday, November 14, 2019\n\n\n\n\n\nTime:\n\n\n \n\n7:00 AM CT / 8:00 AM ET\n\n\n\n\n\nWeb access:\n\n\n \n\nhttps://event.on24.com/wcc/r/2120577/625481B71D93A3177784DC7A779612B0\n\n\n\n\n\nDial In:\n\n\n \n\n(844) 557-8483 (domestic)\n\n\n\n\n\n \n\n\n \n\n(825) 312-2381 (international)\n\n\n\n\n\nConference ID:\n\n\n \n\n4594493\n\n\n\n\n\nInterested parties may access the conference call by dialing in or listening to the simultaneous webcast. Listeners should log on to the website or dial in 15 minutes prior to the call. The webcast will remain available for play back on our website, under investor events and presentations, following the earnings call and for 12 months thereafter. A telephonic replay of the conference call will be available until November 21, 2019, by dialing (800) 585-8367 (US Toll Free), (416) 621-4642 (International), replay passcode 4594493.\n\n\nAbout DiaMedica Therapeutics Inc.\nDiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney diseases and neurological disorders. DiaMedica’s shares are listed on The Nasdaq Capital Market under the trading symbol “DMAC.”\n\n\nFor more information, please visit www.diamedica.com or follow us on Twitter.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20191106005707/en/\n\nScott Kellen\nChief Financial Officer\nPhone: (763) 496-5118\[email protected]\n\nSource: DiaMedica Therapeutics Inc.","length":6310,"tagName":"div"}]